Volume 272, Number 40,
Issue of October 3, 1997
pp. 24921-24926
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
The DNA Binding Domain of the A-MYB Transcription Factor Is
Responsible for Its B Cell-specific Activity and Binds to a B Cell
110-kDa Nuclear Protein
(Received for publication, May 7, 1997, and in revised form, June 24, 1997)
Guo-Guang
Ying
,
Marcello
Arsura
§
,
Martino
Introna
and
Josée
Golay
From the
Laboratory of Molecular Immunohematology,
Department of Immunology and Cell Biology, Istituto Ricerche
Farmacologiche "Mario Negri," via Eritrea 62, 20157 Milano, Italy
and the § Department of Biochemistry, Boston University
School of Medicine, Boston, Massachusetts 02118-2394
Expression studies as well as the use of
transgenic animals have demonstrated that the A-MYB transcription
factor plays central and specific role in the regulation of mature B
cell proliferation and/or differentiation. Furthermore, it is highly
expressed in Burkitt's lymphoma cells and may participate in the
pathogenesis of this disease. We have therefore investigated the
transcriptional activity of A-MYB and its regulation in several human
lymphoid cell lines using co-transfection assays and show that A-MYB is transcriptionally active in all the B cell lines studied, but not in T
cells. In particular the best responder cell line was the Burkitt's
cell line Namalwa. The activity of A-MYB in B and not T cells was
observed when either an artificial construct or the c-MYC
promoter was used as a reporter. Furthermore, the functional domains responsible for DNA binding, transactivation, and negative regulation, previously characterized in a fibroblast context, were
found to have similar activity in B cells. The region of A-MYB
responsible for the B cell specific activity was defined to be the
N-terminal 218 amino acids containing the DNA binding domain. Finally,
a 110-kDa protein has been identified in the nuclei of all the B, but
not T, cell lines that specifically binds to this A-MYB N-terminal
domain. We hypothesize that this 110-kDa protein may be a functionally
important B cell-specific co-activator of A-MYB.